IL-10 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL-10 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL-10 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.03 mg, 0.1 mg |
| Concentration | 0.5 mg/ml |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Polyclonal Antibody to detect IL-10 in human, mouse and rat samples. Background: IL-10 (Interleukin-10), originally known as Cytokine Synthesis Inhibitory Factor (CSIF), is an 20.5 kDa protein containing 161-178 amino acid residues. IL10 is produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytok |
| Immunogen | Immunogen: Recombinant human protein. Positive Control: Western Blot: Jurkat cell lysate |
| Other Names | [CSIF; IL-10; IL10A; TGIF; B-TCGF; GVHDS; MGC126450; MGC126451; RP11-262N9.1; Interleukin-10], [IL10; IL10; CSIF; TGIF; GVHDS; IL-10; IL10A; IL-10; CSIF] |
| Gene, Accession # | [IL-10], Gene ID: 3586, NCBI: NP_000563.1, UniProt: P22301 |
| Catalog # | MBS840916 |
| Price | $150, $325 |
| Order / More Info | IL-10 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies